CLINICAL_TRIALS
trial_result
· 2017-01-23
Clinical Trial Update: The Effect of NN1250 in Subjects With Type 2 Diabetes of Different Race and/or Ethnic Origin [Phase 1]
Summary
A Phase 1 study assessing NN1250 in adults with type 2 diabetes across diverse races/ethnic origins has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED